Enhancing the Natriuretic Peptide System in HFpEF
Conditions: Heart Failure With Preserved Ejection Fraction; Chronic Kidney Diseases Interventions: Drug: MANP; Drug: Sacubitril/Valsartan; Drug: Oral Placebo; Drug: Injection Placebo Sponsor: Horng Chen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2022 Category: Research Source Type: clinical trials
Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
Conditions: Contrast-induced Nephropathy; Chronic Kidney Diseases; Ischemic Heart Disease Interventions: Other: Continue ACEI or ARBs ( Enalapril , Ramipril , Valsartan , Candesartan, Losartan ); Other: Hold ACEI or ARBs Sponsor: An-Najah National University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2022 Category: Research Source Type: clinical trials
